Examination of bone mineral density in patients with varied liver diseases - a cross-sectional study

Table 3 Bone metabolism markers

Marker	PBC	PSC	AIH	HCV	Cysts
Osteocalcin (ng/mL)	14.2	17.2	14.9	14.6	61.9
25-OH vitamin D (nmol/L)	142.4	60.3	49.9	45.9	79.0
PTH (ng/L)	34.7	39.0	44.8	49.7	85.8
Phosphate (mmol/L)	1.1	1.0	1.0	2.1	1.1
Copper (μmol/L)	25.8	27.6	19.9	18.8	27.5
Zinc (μmol/L)	7.1	8.8	8.0	7.6	9.8
Magnesium (mmol/L)	0.8	0.8	0.8	0.8	0.8
Calcium (mmol/L)	2.3	2.3	2.3	2.1	2.3
Creatinine (μmol/L)	88	95	83	91	3101
AST (U/L)	85	74	121	98	63
ALT (U/L)	72	69	115	104	52

¹Several patients with hepatic cysts presented with concomitant polycystic kidney disease and dialysis-dependent renal failure, explaining the markedly elevated creatinine levels. PBC: Primary biliary cholangitis; PSC: Primary sclerosing cholangitis; HCV: Hepatitis C virus infection; AIH: Autoimmune hepatitis; Cysts: Hepatic cystic disease; PTH: Parathyroid hormone; AST: Aspartat aminotransferase; ALT: Alanin aminotransferase.